Perinatal management of neonatal alloimmune thrombocytopenia associated with anti-group A antibody.
Perinatal management of neonatal alloimmune thrombocytopenia associated with anti-group A antibody.
复制标题
与抗 A 组抗体相关的新生儿同种免疫性血小板减少症的围产期管理。
DOI:
10.1111/tme.12178
复制
发表时间:
2015
期刊:
影响因子:
--
通讯作者:
Saitoh S.
中科院分区:
文献类型:
--
作者:
Ueda H;Sugiura T;Katano K;Matsuhashi M;Kato S;Ito K;Nagasaki R;Kato T;Tsuno NH;Saitoh S.
ObjectiveTo prevent neonatal alloimmune thrombocytopenia due to anti‐group A antibody perinatal management was performed.BackgroundWe previously reported a case of severe intracranial haemorrhage associated with neonatal alloimmune thrombocytopenia due to anti‐group A isoantibody.Material/MethodsA 40‐year‐old Japanese woman, gravida 4 para 1, was pregnant with her second baby. The previous sibling developed severe thrombocytopenia and died 10 days after birth due to intracranial haemorrhage. He was diagnosed with neonatal alloimmune thrombocytopenia; the causative antibody was found to be the anti‐group A antibody. Prednisone was started at 7 weeks' gestational age. Intravenous immunoglobulin 1 g kg−1week−1was started at 29 weeks' gestational age and continued to delivery. Serological studies and genotyping were performed.ResultsThe second boy was delivered at 33 weeks' gestational age by caesarean section. He was discharged without intracranial haemorrhage or thrombocytopenia. The anti‐group A antibody titre in the maternal serum was 2048–4096 (normal range: 4–64). The anti‐group A antibody titre in the newborn's serum was 4. Cross‐matching between the maternal serum and the paternal platelets was positive.ConclusionOwing to the history of neonatal alloimmune thrombocytopenia causing intracranial haemorrhage and death of the previous sibling, strict follow‐up of the subsequent pregnancy was conducted.